SCHEMBL3559272

SCHEMBL3559272

CCCCN(c1ccccc1CCc1ccc(C(=O)O)cc1)S(=O)(=O)c1ccccc1OC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
RXRG P48443 1/20 0.43
PPARG P37231 4/20 0.41
PPARD Q03181 4/20 0.41
PPARA Q07869 4/20 0.41
ALOX5 P09917 3/20 0.41
TRPM8 Q7Z2W7 4/20 0.41
CYP2C9 P11712 1/20 0.40
LPAR1 Q92633 1/20 0.39
LPAR5 Q9H1C0 1/20 0.39
PTGES O14684 2/20 0.38
TAS2R14 Q9NYV8 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
PTGER1 P34995 2/20 0.37
PTGER4 P35408 1/20 0.37
PTGER3 P43115 1/20 0.37
PTGER2 P43116 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558815 0.86 TRPM8 (0.56) ALOX5TRPM8PTGER1
SCHEMBL3555950 0.85 TAS2R14 (0.46) ALOX5LPAR1LPAR5PTGESTAS2R14
SCHEMBL3558519 0.83 ALOX5 (0.45) RXRARXRBRXRGALOX5TRPM8
SCHEMBL3554881 0.82 TRPM8 (0.55) ALOX5TRPM8PTGESPTGER1
SCHEMBL3558983 0.82 ALOX5 (0.42) ALOX5LPAR1LPAR5PTGESTAS2R14
SCHEMBL3560865 0.82 ALOX5 (0.57) ALOX5PTGESTAS2R14MEN1ALDH1A1
SCHEMBL3553576 0.81 ALOX5 (0.47) ALOX5LPAR1LPAR5PTGESTAS2R14
SCHEMBL3554681 0.81 SLC16A3 (0.55) ALOX5TRPM8PTGESMEN1KMT2A
SCHEMBL3554947 0.81 SLC16A3 (0.48) ALOX5LPAR1LPAR5PTGESTAS2R14
SCHEMBL3563471 0.81 TAS2R14 (0.44) ALOX5PTGESTAS2R14ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 RXRA 1293/4885RXRB 1002/4885RXRG 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.